Chemo Group and mAbxience achieved the “Group A” and “Very Good” qualifications in the PROFARMA programme after an evaluation of its resources and industrial, economic and RD&I results. Profarma is a programme sponsored by the Ministry of Industry and Energy of Spain with the objective of fostering competition in the pharmaceutical industry, particularly in areas like investment in new plants and new production technologies. Each year, it classifies companies in groups and categories based on their excellence in a range of industrial, economic and RD&I aspects.